GATA2-AS1, GATA3-AS1, and SIX3-AS1 survival data are reported from RNA sequencing of 143 NB patient tissues (TARGET, 2018), while DBH-AS1 survival data are reported from 249 Agilent microarray analyses of NB samples (TARGET, 2018). This evidence concerns the gene GATA3 and neuroblastoma.